IOSP - Innospec Inc.
NASDAQ
->
Basic Materials
->
Specialty Chemicals
Englewood,
United States
Type: Equity
IOSP price evolution
IOSP
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $240.2 | $270.1 | $203.7 | |
| Short term investments | ||||
| Net receivables | $327.6 | $300.3 | $318.2 | $359.8 |
| Inventory | $319.3 | $313.5 | $304.3 | $300.1 |
| Total current assets | $965.6 | $876.8 | $912.9 | $885.7 |
| Long term investments | ||||
| Property, plant & equipment | $323.7 | $319.8 | $312.2 | $313.4 |
| Goodwill & intangible assets | $449.6 | $455.2 | $456.6 | |
| Total noncurrent assets | $823.5 | $819.9 | $821.7 | |
| Total investments | ||||
| Total assets | $1797.7 | $1700.3 | $1732.8 | $1707.4 |
| Current liabilities | ||||
| Accounts payable | $169 | $147.7 | $166.4 | $163.6 |
| Deferred revenue | ||||
| Short long term debt | $14.9 | $13.6 | $13.6 | |
| Total current liabilities | $373.1 | $332.8 | $364.9 | $371.5 |
| Long term debt | $33.2 | $30 | $31.6 | |
| Total noncurrent liabilities | $171.6 | $181.7 | $186.3 | |
| Total debt | $48.1 | $43.6 | $45.2 | |
| Total liabilities | $554.3 | $504.4 | $546.6 | $557.8 |
| Shareholders' equity | ||||
| Retained earnings | $1115.2 | $1081.8 | $1069.6 | $1028.2 |
| Other shareholder equity | -$145.3 | -$160.6 | -$155.4 | -$148.1 |
| Total shareholder equity | $1192.6 | $1183.6 | $1147.1 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $203.7 | $147.1 | $141.8 | $105.3 |
| Short term investments | ||||
| Net receivables | $359.8 | $334.6 | $284.5 | $221.4 |
| Inventory | $300.1 | $373.1 | $277.6 | $220 |
| Total current assets | $885.7 | $872.6 | $728.1 | $566.2 |
| Long term investments | ||||
| Property, plant & equipment | $313.4 | $266.2 | $249.8 | $250.9 |
| Goodwill & intangible assets | $456.6 | $403.8 | $421.8 | $446.5 |
| Total noncurrent assets | $821.7 | $731.1 | $842.8 | $831.2 |
| Total investments | ||||
| Total assets | $1707.4 | $1603.7 | $1570.9 | $1397.4 |
| Current liabilities | ||||
| Accounts payable | $163.6 | $165.3 | $148.7 | $98.7 |
| Deferred revenue | ||||
| Short long term debt | $13.6 | $13.9 | $12.5 | $11.8 |
| Total current liabilities | $371.5 | $405.8 | $336.6 | $252.4 |
| Long term debt | $31.6 | $31.4 | $23.1 | $29 |
| Total noncurrent liabilities | $186.3 | $157.5 | $201.3 | $200.1 |
| Total debt | $45.2 | $45.3 | $35.6 | $40.8 |
| Total liabilities | $557.8 | $565.7 | $537.9 | $452.5 |
| Shareholders' equity | ||||
| Retained earnings | $1028.2 | $924.2 | $822.9 | $758.6 |
| Other shareholder equity | -$148.1 | -$145.2 | -$46.9 | -$57.3 |
| Total shareholder equity | $1147.1 | $1038 | $1032.4 | $944.4 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $443.4 | $435 | $500.2 | $494.7 |
| Cost of revenue | $308.1 | $344.5 | $339 | |
| Gross Profit | $124.1 | $126.9 | $155.7 | $155.7 |
| Operating activities | ||||
| Research & development | $12.2 | $11.8 | $8.9 | |
| Selling, general & administrative | $73.4 | $92.7 | $102.3 | |
| Total operating expenses | $78.6 | $85.6 | $104.4 | $111.2 |
| Operating income | $41.3 | $51.3 | $44.5 | |
| Income from continuing operations | ||||
| EBIT | $41.6 | $55.3 | $43.8 | |
| Income tax expense | $11.4 | $12.5 | $13.9 | $7.5 |
| Interest expense | -$1.6 | -$2.1 | -$1.5 | |
| Net income | ||||
| Net income | $33.4 | $31.2 | $41.4 | $37.8 |
| Income (for common shares) | $31.2 | $41.4 | $37.8 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1948.8 | $1963.7 | $1483.4 | $1193.1 |
| Cost of revenue | $1357.7 | $1377 | $1048.5 | $850.4 |
| Gross Profit | $591.1 | $586.7 | $434.9 | $342.7 |
| Operating activities | ||||
| Research & development | $41.7 | $38.7 | $37.4 | $30.9 |
| Selling, general & administrative | $387.8 | $360.7 | $267.2 | $237 |
| Total operating expenses | $429.5 | $399.4 | $304.6 | $309 |
| Operating income | $161.6 | $187.3 | $130.3 | $33.7 |
| Income from continuing operations | ||||
| EBIT | $172.1 | $185.7 | $135.9 | $41.5 |
| Income tax expense | $35.3 | $51.6 | $41.3 | $11 |
| Interest expense | -$2.3 | $1.1 | $1.5 | $1.8 |
| Net income | ||||
| Net income | $139.1 | $133 | $93.1 | $28.7 |
| Income (for common shares) | $139.1 | $133 | $93.1 | $28.7 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $31.2 | $41.4 | $37.8 | |
| Operating activities | ||||
| Depreciation | $11.1 | $10.4 | $10.2 | |
| Business acquisitions & disposals | -$0.2 | -$34.7 | ||
| Stock-based compensation | $2.1 | $2.1 | $2.1 | |
| Total cash flows from operations | $4.7 | $80.6 | $72.4 | |
| Investing activities | ||||
| Capital expenditures | -$15.2 | -$14.3 | -$21.1 | |
| Investments | ||||
| Total cash flows from investing | -$41.4 | -$15.4 | -$14.3 | -$55.8 |
| Financing activities | ||||
| Dividends paid | -$19 | -$19 | -$17.9 | |
| Sale and purchase of stock | -$0.2 | $0.3 | $0.1 | |
| Net borrowings | -$2.3 | |||
| Total cash flows from financing | -$17.5 | -$18.9 | $0.5 | -$20.4 |
| Effect of exchange rate | $0.2 | -$0.3 | -$0.4 | $0.3 |
| Change in cash and equivalents | $100.1 | -$29.9 | $66.4 | -$3.5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $139.1 | $133 | $93.1 | $28.7 |
| Operating activities | ||||
| Depreciation | $39.3 | $40.1 | $42.7 | $46 |
| Business acquisitions & disposals | -$34.7 | |||
| Stock-based compensation | $8 | $6.7 | $4.4 | $5.8 |
| Total cash flows from operations | $207.3 | $81.7 | $93.2 | $145.9 |
| Investing activities | ||||
| Capital expenditures | -$77.1 | -$42.1 | -$36.2 | -$29.7 |
| Investments | ||||
| Total cash flows from investing | -$111.8 | -$42.1 | -$36.2 | -$29.7 |
| Financing activities | ||||
| Dividends paid | -$35.1 | -$31.7 | -$28.8 | -$25.6 |
| Sale and purchase of stock | -$0.2 | -$3.7 | $9.3 | $0.1 |
| Net borrowings | -$2.3 | -$0.1 | -$0.6 | -$61.1 |
| Total cash flows from financing | -$39 | -$33.7 | -$20 | -$86.8 |
| Effect of exchange rate | $0.1 | -$0.6 | -$0.5 | $0.2 |
| Change in cash and equivalents | $56.6 | $5.3 | $36.5 | $29.6 |
News
Fundamentals
| Market cap | $2.62B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 24.94M |
| Revenue | $1.87B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $143.80M |
| Revenue Q/Q | -4.46% |
| Revenue Y/Y | -4.66% |
| P/E ratio | 18.25 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.40 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $5.77 |
|---|---|
| ROA | 8.29% |
| ROE | N/A |
| Debt/Equity | 0.49 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.59 |
| Quick ratio | 1.73 |